Organization
Galmed Pharmaceuticals
2 clinical trials
Clinical trial
A Phase 1, Double-blind, Single and Multiple-Dose Study of Safety, Tolerability and Pharmacokinetics of Amilo-5MER in Healthy VolunteersStatus: Completed, Estimated PCD: 2021-07-01
Clinical trial
An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability of Aramchol and to Determine the Mass Balance Recovery, Metabolite Profile and Metabolite Identification to Healthy Male SubjectsStatus: Completed, Estimated PCD: 2020-08-11